新聞集錦
NEW

臺灣升格歐洲分子生物聯盟準會員；默克斥7600萬美元擴張ADC生物藥CDMO量能；避免鴉片類成癮！FDA批准首款羥考酮速效錠治療嚴重疼痛
生技醫藥
NEW

強生化學、耀勝電子股份交換 跨界結盟擴生醫布局 

新聞集錦
NEW

10/30《生技股動態》

GBI International
GBIHighlights

FDA approves Onivyde® as a first-line therapy for metastatic pancreatic adenocarcinoma

2024-02-28/GlobalBio & Investment
**#FDAApproval**ExcitingnewsforPharmaEngineInc(4162.TWO)!FDAapproves#Onivyde®asafirst-linetherapyformetastaticpancreaticadenocarcinoma,markingapotentialnewstandardofcare.PharmaEngine'scollabor...
GBI International
GBIHighlights

The potential of next-generation microbiome therapy in clinical applications (8th AMC)

2024-02-28/GlobalBio & Investment
*#MicrobiomeTherapy**Canthegutmicrobiotarevolutionizecancertreatment?Insightsfromthe8thAsiaMicrobiomeConference(#AMC),heldbyIBCAcademiaSinica,NationalTaiwanUniversityHospital,and圖爾思生物科技BIOTOOLSCO.,LTD...
GBI International
GBIHighlights

Chang Gung Medical Foundation teams up with Gilead Sciences to accelerate early-stage clinical trial

2024-02-28/GlobalBio & Investment
**#ClinicalTrials**ChangGungMedicalFoundationteamsupwithGileadSciencestoaccelerateearly-stageclinicaltrials,focusingon#oncology.Thecollaborationaimstoadvanceclinicaltrialsintumorresearch,preclinicalco...
GBI International
GBIHighlights

GBI Spotlight: Dr. Han-Chung Wu

2024-02-28/GlobalBio & Investment
#GBISpotlight:Dr.Han-ChungWu(吳漢忠)MeetDr.Han-ChungWu,themanbehindthedevelopmentofprecisiontherapythroughinnovativephagedisplaytechnology.AstheDirectorofBioTrecatNBRP,AcademiaSinica,heisawell-knownfigur...
GBI International
GBIHighlights

Meet David Lee, the visionary founder and CEO of Singular Wings Medical

2024-02-28/GlobalBio & Investment
**#Meet#StartupCEOs**MeetDavidLee(李維中),thevisionaryfounderandCEOofSingularWingsMedical.Fromtheelectronicsindustrytoentrepreneurship,hemerges#healthcarewith#electronics,craftinginnovativesolutionsforme...
GBI International
GBIHighlights

Merck's Keytruda Leads 2023 Sales!

2024-02-28/GlobalBio & Investment
**Merck'sKeytrudaLeads2023Sales!**Merck'sKeytrudaemergesasthetop-sellingdrugof2023,amassinganimpressive$25billioninsales.MerckCFOCarolineLitchfieldattributesKeytruda'ssurgein2023torecentap...
GBI International
GBIHighlights

TBMC partners with U.S. firm National Resilience, Inc. for advanced bioprocessing

2024-02-28/GlobalBio & Investment
**ExcitingNews!TaiwanBio-ManufacturingCorporation(#TBMC),the‘biotechTSMC,’partnerswithU.S.firmNationalResilience,Inc.foradvancedbioprocessing.ChairmanMichelChu(瞿志豪)outlinesaglobalapproachf...
GBI International
GBIHighlights

AnBogen Therapeutics hits a milestone: completes USD 12.5M Series A funding round!

2024-02-28/GlobalBio & Investment
**AnBogenTherapeuticshitsamilestone:completesUSD12.5MSeriesAfundinground!**InastrategicmoveledbyCDIBCapitalInternationalCorporation,AnBogenTherapeuticsproudlyannouncesthesuccessfulclosureofitsSeriesAf...
GBI International
GBIHighlights

Revolutionizing Antibiotics: Xtraordinary Discovery by NCHU team!

2024-02-28/GlobalBio & Investment
*RevolutionizingAntibiotics:XtraordinaryDiscoverybyNationalChungHsingUniversity(#NCHU)team!**NCHUresearchersmadeagroundbreakingdiscoveryinantibioticdevelopment.Theyfoundanucleotidesignalingmoleculetha...
GBI International
GBIHighlights

EirGenix, Inc. and Sartorius delves into critical aspects such as sterile filtration

2024-02-28/GlobalBio & Investment
**MasteringQualityAssurance!**SartoriusTaiwanelevatesproductqualitythroughrobustfiltrationsystemtesting.RZLin,aSartoriusTechSpecialist,underscoresthecrucialroleofQualityRiskManagement(#QRM)inmaintaini...
生技醫藥
阿茲海默症 免疫學

《Neuron》首揭阿茲海默患者血液免疫基因變化 後天環境影響大?!

2024-02-28/記者 巫芝岳
近(9)日，美國西北大學(NorthwesternUniversity)醫學院的研究團隊首次發現，阿茲海默症患者的血液中，發生許多免疫相關基因的改變，推測可能是過去曾遭病毒感染、環境污染，或因某些生活方式而導致，未來可望開發為新的治療標靶。該研究發表於期刊《Neuron》。研究人員發現，該血液中的變化為一項表觀遺傳學(epigenetics)的改變，意即非源於DNA序列變化的遺傳因素，而是患者後天...
生技醫藥
DNA AI

《Nature》子刊：創新「合成DNA」演算法 加速細胞狀態研究、助藥物開發

2024-02-27/記者 巫芝岳
近(5)日，德國馬克斯·德爾布呂克分子醫學中心(MDC)的，開發出一項演算法，能幫助科學家設計「可即時指示細胞狀態」的合成DNA片段，該工具能讓科學家在「尚未了解細胞某狀態背後完整機制」的情況下，就可對該狀態進行調控；未來有望用於藥物篩選，或開發基因和細胞療法。研究論文發表於期刊《NatureCommunications》。過去，科學家要調控細胞的某些功能時，常須先暸解其背後精確的基...

TOP
  • Global Bio and Investment Monthly
  • 讀者服務電話：+886 2 2726 1065時間：週一 ~ 週五 09:00 ~ 18:00
  • 服務信箱：[email protected]
  • 地址：110臺北市信義區信義路六段29號2樓之一, Taiwan

我們的服務